Corey J. Langer, MD, discusses the need for reflex testing in patients with non–small cell lung cancer.
Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer
John F. Lazar, MD, discusses risk stratification for chemotherapy and adjuvant therapy in lung cancer.
Rodolfo Bordoni, MD, discusses the utility of adjuvant osimertinib in lung cancer.
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5